Finding 'off the radar' names that can deliver solid earnings and revenue growth will be key to managing one's growth portfolio.
These recently downgraded names are displaying both quantitative and technical deterioration.
Also, I really like the idea of owning the shares - you have time - prior to the split into two firms.
There are reasons to be optimistic about Hims & Hers Health and OptiNose Inc.
It's hard to see stock valuations rising when inflation remains high and the economy appears headed for a recession if it isn't in one already.
A few homebuilders and healthcare stocks seem likely to hold up better than most of the market in a recession.
The CHNG chart is at an interesting juncture.
Here's how to approach CANO as the shares have made a bottom formation.
The healthcare provider is set to report earnings Friday.
The biotech's latest earnings release is set for Wednesday.